Skip to main content
. 2008 Oct 6;26(32):5220–5226. doi: 10.1200/JCO.2008.16.3766

Table 6.

No. of Precautions Followed by Surgical Procedure, Arm Dominance, and Lymphedema Category

Parameter No. of Patients Mean SD Median Range P
SLNB
    Alone 600 4.3 1.9 4 0-13 < .0001
    Followed by ALND 336 5.1 1.5 5 1-11
Arm
    Dominant 471 4.7 1.8 5 0-13 .24
    Non-dominant 465 4.5 1.9 4 0-13
L > 2 cm
    No 850 4.5 1.8 4 0-13 < .0001
    Yes 86 5.3 1.9 5 0-11
Patient-reported current swelling
    No 827 4.4 1.8 4 0-13 < .0001
    Yes 109 5.7 1.8 5 1-11
Swelling by LBCQ
    No 859 4.5 1.8 4 0-13 < .0001
    Yes 77 5.5 2.0 5 0-11
Lymphedema
    No* 786 4.4 1.8 4 0-13 < .0001
    Asymptomatic* 41 4.7 1.7 5 0-8
    Symptomatic nonlymphedema* 64 5.5 1.8 5 1-10
    Symptomatic* 45 5.9 1.9 6 3-11

NOTE. L > 2 cm, definition of measured lymphedema as calculated by formula L = (If/uIb) –(Cf/uCb) where I indicates ipsilateral upper-extremity circumference, C indicates contralateral upper-extremity circumference, f/u indicates follow-up, and b indicates baseline.

Abbreviations: SD, standard deviation; SLNB, sentinel lymph node biopsy; ALND, axillary lymph node dissection; LBCQ, Lymphedema and Breast Cancer Questionnaire; No lymphedema, no perceived swelling and L ≤ 2 cm; asymptomatic lymphedema, no perceived swelling but L > 2 cm; symptomatic non-lymphedema, perceived swelling but L ≤ 2 cm; symptomatic lymphedema, perceived swelling and L > 2 cm.